Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Altogen's siRNA Transfection Reagent; Exiqon's Stem Cell qPCR Panel

Premium

Altogen Biosystems has launched a new pancreas-targeted in vivo RNAi transfection reagent.

According to the company, the reagent was designed to deliver siRNAs into the pancreas, but is compatible for transfection of any negatively charged molecules including RNA, DNA, proteins, and small molecules.


Exiqon announced the availability of stem cell-focused microRNA PCR panels.

The panels contain “all relevant” stem cell miRNAs in 96- and 384-well plates, according to the firm.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.